IMNN - Imunon Inc
IEX Last Trade
1.14
0.050 4.386%
Share volume: 319,409
Last Updated: Fri 30 Aug 2024 09:59:45 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.09
0.05
4.59%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-11 | 2023-08-10 | 2023-11-14 | |
Total revenue | 125.000 K | 125.000 K | 125.000 K | 125.000 K | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 125.000 K | 125.000 K | 125.000 K | 125.000 K | 0.000 | 0.000 | 0.000 | |
0.00% | 0.00% | 0.00% | -100.00% | nan% | nan% | |||
Operating expenses | 5.967 M | 6.103 M | 6.300 M | 7.052 M | 5.684 M | 5.474 M | 3.904 M | |
Selling general and admin | 2.872 M | 2.877 M | 3.891 M | 4.048 M | 3.065 M | 2.340 M | 1.923 M | |
Research and development | 3.095 M | 3.226 M | 2.409 M | 3.003 M | 2.620 M | 3.134 M | 1.981 M | |
Total expenses | 5.967 M | 6.103 M | 6.300 M | 7.052 M | 5.684 M | 5.474 M | 3.904 M | |
2.28% | 3.22% | 11.94% | -19.39% | -3.70% | -28.68% | |||
Operating income | -5.842 M | -5.978 M | -6.175 M | -6.927 M | -5.684 M | -5.474 M | -3.904 M | |
Ebit | -5.842 M | -5.978 M | -6.175 M | -6.927 M | -5.684 M | -5.474 M | -3.904 M | |
Pretax income | -10.474 M | -6.043 M | -6.148 M | -14.800 M | -5.591 M | -5.559 M | -3.477 M | |
-42.31% | 1.74% | 140.71% | -62.22% | -0.58% | -37.46% | |||
Income tax | 0.000 | 0.000 | 0.000 | -1.567 M | 0.000 | 0.000 | 0.000 | |
Net income basic | -10.474 M | -6.043 M | -6.148 M | -13.233 M | -5.591 M | -5.559 M | -3.477 M | |
42.31% | -1.74% | -115.23% | 57.75% | 0.58% | 37.46% | |||
Net income | -10.474 M | -6.043 M | -6.148 M | -13.233 M | -5.591 M | -5.559 M | -3.477 M | |
42.31% | -1.74% | -115.23% | 57.75% | 0.58% | 37.46% |